![]() | ![]() |
Formats:
|
||||||||||||||
Copyright © 2006 by The National Academy of Sciences of the USA Developmental Biology Molecular characterization of embryonic gonads by gene expression profiling in Drosophila melanogaster *Okazaki Institute for Integrative Bioscience, National Institute for Basic Biology, National Institutes of Natural Sciences, Higashiyama, Myodaiji, Okazaki 444-8787, Japan; †Department of Basic Biology, School of Life Science, Graduate University for Advanced Studies, Nishigonaka, Myodaiji, Okazaki 444-8585, Japan; and §Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Honcho, Kawaguchi 332-0012, Japan ¶To whom correspondence should be addressed. E-mail: skob/at/nibb.ac.jp Edited by Allan C. Spradling, Carnegie Institution of Washington, Baltimore, MD, and approved July 13, 2006 ‡S.S. and Y.K. contributed equally to this work. Author contributions: S.S. and S.K. designed research; S.S., Y.K., C.N., and S.K. performed research; S.S., Y.K., and S.K. analyzed data; and S.S. and S.K. wrote the paper. Received May 10, 2006. Freely available online through the PNAS open access option. This article has been cited by other articles in PMC.Abstract In many animal species, germ-line progenitors associate with gonadal somatic cells to form the embryonic gonads (EGs) that later develop into functional organ producing gametes. To explore the genetic regulation of the germ-line development, we initiated a comprehensive identification and functional analysis of the genes expressed within the EGs. First, we generated a cDNA library from gonads purified from Drosophila embryos by FACS. Using this library, we catalogued the genes expressed in the gonad by EST analysis. A total of 17,218 high-quality ESTs representing 3,051 genes were obtained, corresponding to 20% of the predicted genes in the genome. The EG transcriptome is unexpectedly distinct from that of adult gonads and includes an extremely high proportion of retrotransposon-derived transcripts. We verified 101 genes preferentially expressed in the EGs by whole-mount in situ hybridization. Within this subset, 39 and 58 genes were expressed predominantly in germ-line and somatic cells, respectively, whereas four genes were expressed in the both cell lineages. The gonad-enriched genes encompassed a variety of predicted functions. However, genes implicated in SUMOylation and protein translation, including germ-line-specific ribosomal proteins, are preferentially expressed in the germ line, whereas the expression of various retrotransposons and RNAi-related genes are more prominent in the gonadal soma. These transcriptome data are a resource for understanding the mechanism of various cellular events during germ-line development. Keywords: expressed sequence tag, germ cell, retrotransposon, pole cell The germ line is the only cell type that transmits genetic materials from one generation to the next during sexual reproduction. In many animal species, germ-line progenitors migrate within embryos to associate with gonadal somatic cells to form the embryonic gonads (EGs) that will later develop into a fully functional organ capable of producing gametes. In Drosophila, the germ-line progenitors, or pole cells, form at the posterior pole region of the early embryos (1, 2). Pole cells then migrate toward the mesodermal layer, where they associate with the specialized mesodermal cells known as somatic gonadal precursors. Eventually, the somatic cells encapsulate the pole cells to form EGs. Within the gonads, the pole cells undergo oogenesis or spermatogenesis and differentiate into germ cells during postembryonic development. Pole cells that fail to be encapsulated within the gonads eventually degenerate without producing germ cells (3). Within the EGs, distinct cellular events associated with germ-line development occur, such as resumption of germ-line proliferation (4, 5), selection of the germ-line stem cell (6), gonad morphogenesis (7), and cellular communication between germ-line and somatic cells (8–10). Recent studies have also revealed that the male germ-line stem cell niche is already specified in the EG (ref. 11; Y.K., S.S., K. Arita, and S.K., unpublished data). Despite the importance of the EG in germ-line development, only limited information is available, regarding which genes are expressed in the EG although transcriptome data of adult testes and ovaries have accumulated (12, 13). Thus, we attempted to identify the genes expressed within the EGs by a direct and comprehensive approach. In Drosophila, transcriptome analysis of individual organs and cell types has been hampered by the smallness of their size. To overcome this problem, we have developed an efficient method to isolate EGs by flow cytometry (14). We generated a cDNA library from purified gonads and obtained 17,218 valid ESTs representing 3,051 genes, all of which were examined by whole-mount in situ hybridization (WISH). The transcripts from 101 genes were enriched in the EG. These genes encompass a wide array of molecular and biological processes, as deduced from the Gene Ontology (GO) categories in the fly database. Here, we highlight five functional categories of genes enriched in the EG and discuss their roles. Results and Discussion Purification of EG by FACS and Generation of ESTs. We used FACS to isolate EG from transgenic Drosophila embryos harboring the germ-line marker EGFP-vasa (15). Embryos at 10–18 h after egg laying were homogenized without protease treatment to keep the gonad intact. From these homogenates, gonads containing both GFP-positive pole cells and GFP-negative gonadal somatic cells were separated from the remaining tissue by FACS. With this procedure, we were able to obtain a highly enriched fraction of EG, as confirmed by microscopy and quantitative PCR (14). We constructed an EG cDNA library (EG library) from poly(A)+ RNA from a pool of ≈25,000 FACS-sorted EGs. We sequenced 12,977 cDNA clones from the 5′ end and 6,755 from the 3′ end. After removing low-quality and contaminating sequences, 17,218 high-quality reads were obtained (DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank accession nos. BP540206–BP560422). When aligned to Drosophila melanogaster genomic sequences, 15,384 (90.1%) ESTs mapped to euchromatic genomic regions and 434 (2.5%) to heterochromatic genomic regions. The remainder, 1,254 ESTs (7.4%), mapped to multiple loci within the genome; these included 974 highly repetitive sequences (≥10 hits in the genome). Compared with the public EST collections, this EG library includes a significantly higher proportion of repetitive sequences (Fig. 1
We aligned each EST with a reference transcript set in the Drosophila database (FlyBase, http://flybase.net) and assigned it to a gene. In total, we consolidated 17,072 ESTs derived from the EG library into a nonredundant set of 3,051 genes; these correspond to ≈20% of the predicted genes in D. melanogaster. Because our EST analysis was nearly saturating (see Supporting Text, which is published as supporting information on the PNAS web site), it covers most of the gene repertoire of the EG transcriptome. All identified genes expressed in the EG are listed in Table 3, which is published as supporting information on the PNAS web site. Using the National Center for Biotechnology Information (NCBI) UniGene-based classification, we compared the gene sets expressed by EGs, adult gonads (AGs; ovary + testis), and other tissues (OTs). Genes represented in all three collections are regarded as those with “housekeeping” functions (1,809 UniGenes; 60.8% of EG UniGene collection). Except the housekeeping genes, we observed that the proportion of genes present in both the EG and AG collections was low (Fig. 2
Overview of Comprehensive Whole-Mount in Situ Hybridization (WISH). All 3,051 genes represented in our EG library were subjected to WISH to examine their distribution within the embryo. Overall, we obtained useful expression data for 2,388 genes. Although most of them showed ubiquitous distribution, we found that transcripts from 101 genes were enriched in the EG, as summarized in Table 1. We further examined their distribution within the gonads by double-staining embryos with a RNA probe for each transcript and an anti-VASA antibody to distinguish the germ-line and somatic expression of the transcripts within the gonads. We identified 39 RNAs that are expressed predominantly in pole cells, 58 that are expressed in gonadal somatic cells, and 4 that are expressed in both cell types (Table 1, Fig. 3
We investigated the temporal expression patterns of transcripts enriched in pole cells by WISH. Embryos at various developmental stages were examined (Fig. 4, which is published as supporting information on the PNAS web site), and three major expression patterns were extracted (Types I, II and III). Transcripts with the Type I expression pattern are first observed in the pole cells during their migration through the posterior midgut epithelium and remain detectable after the coalescence of the gonads. Transcripts from vasa, RpL22-like, RpS19b, CG10990, CG4415, TfIIA-S, and Ssb-c31b exhibit this type of expression. Because the pole cells are transcriptionally inactive until they migrate (16), these transcripts are some of the earliest zygotic transcripts in the pole cells. Given that their transcription is initiated in the pole cells before coalescing with the gonadal somatic cells, we speculate that their expression is autonomously initiated by maternal factors partitioned into the pole cells, rather than an inductive signal from the gonadal soma. Indeed, the expression of some Type I genes also was detectable “lost” pole cells that failed to be incorporated within the gonads. Transcripts with a Type II expression pattern are observed in various tissues before gonad formation but are enriched in pole cells after they associate with the gonadal somatic cells. Transcripts for smt3, Uba2, lwr, Top2, and grp display this type of expression pattern. Type III expression includes transcripts that accumulate in the pole cells throughout embryogenesis. These transcripts present in the early pole cells are presumably maternal in origin, whereas zygotic transcription may occur at later stages. This type includes transcripts from ovo, stai, Hsp26, Hsp27, Hsp83, and zpg. Functional Classification of EG-Enriched Genes. To characterize the EG transcriptome, we assigned GO terms to each EG-enriched gene according to FlyBase annotations. As shown in Table 4, which is published as supporting information on the PNAS web site, EG-enriched genes represent a broad range of biological and molecular functions. Our statistical analysis showed that some of the categories were significantly overrepresented in the list of EG-enriched genes (Table 2). Among them, five categories are highlighted and discussed in detail.
Germ-Line Development. We found that genes in the GO category “germ cell development” were overrepresented in the list of EG-enriched genes (Table 2). It is generally expected that genes responsible for germ-line development are predominantly expressed in the gonads. However, their functions are known to be required within the AGs. For example, piwi is expressed in the somatic cells adjacent to germ-line stem cells and is essential for stem cell self renewal (17). zpg is required for survival of differentiating early germ cells in AGs (18), and armi represses oskar translation in ovaries and Ste expression in testes (19, 20). Although their functions during embryogenesis are unclear, these genes were expressed in the EGs. A similar precocious expression has been reported for meiotic genes; a subset of the genes responsible for meiotic division is expressed in pole cells during embryogenesis, whereas meiosis is initiated later at the postembryonic stages (21). It is possible that transcription of these gametogenesis-related genes initiates in the EGs, but posttranscriptional repression restricts the function of these genes until the onset of gametogenesis. Although we cannot exclude the possibility that these genes may have additional functions, our observations are consistent with the notion that the EG acquires at least a part of the potential to carry out gametogenesis. LTR Retrotransposons. We observed that a surprisingly large number of EG ESTs (>1,000 ESTs) were derived from retrotransposons; this population corresponds to 7% of the EG EST collection. This proportion was significantly larger than in other public EST collections (Fig. 1 The significance of the retrotransposon expression in gonadal somatic cells is unclear. Expression and retrotransposition in germ line would be a more effective strategy for retrotransposons to propagate them in a heritable manner from one generation to the next. An interesting case has been reported in a specific strain called RevI, in which the retrotransposon ZAM is expressed in the follicle cells of the adult ovaries and forms virus-like particles that transfer to neighboring oocytes (25). A similar transfer has been reported for the virus-like particles originating from the gypsy retrotransposon in the ovaries of flamenco mutant females (26). This translocation of virus-like particles may couple with yolk transfer from follicle cells to the oocytes by exo- and endocytosis and/or through gap junctions (25, 27). Retrotransposons may exploit the intimate link between the follicle cells and the oocytes to obtain additional access to gametes. This somatic expression may circumvent a host defense against retrotransposons in the germ line (28, 29). However, it is worthwhile to note that the expression of ZAM and gypsy retrotransposons are detectable only in certain genetic backgrounds, such as RevI and the flamenco mutant, respectively (25, 27). Thus, their expression is normally repressed in the follicle cells. In contrast, in our experiments, transcripts from various retrotransposons are preferentially expressed in gonadal somatic cells during normal embryogenesis. One possibility is that their early transcription is regulated differently, and the transcripts are inactivated by a posttranscriptional regulatory mechanism (see below). RNAi. Among the Drosophila genes, 11 are annotated to be associated with “RNAi” (FlyBase), a mechanism by which dsRNA induces gene silencing. Transcripts from nine RNAi-related genes are constituents of the EG EST collection. Among them, three genes, piwi, armi, and Dcr-2, were expressed predominantly in the EGs by WISH (Fig. 3 RNAi-mediated mechanisms contribute to host defenses against transposons and viruses (30–32). A subset of mutations that disable the RNAi mechanism mobilizes families of transposable elements. For example, the LTR retrotransposons gypsy and ZAM are regulated by a mechanism that depends on piwi (30–32). In Drosophila, transposons and repeated sequences, including P-element, Stellate, I-element, and gypsy, are repressed by a trans-silencing mechanism termed “cosuppression” that targets any transposons containing homologous sequences to the “trigger” transcripts by small interfering RNA (siRNA; refs. 33–35). Based on the aforementioned observations that transcripts from various LTR retrotransposons and the RNAi-related genes are both enriched in the gonadal somatic cells of the embryos, we hypothesize that LTR-retrotransposon transcripts would be the “trigger;” they are processed by RNAi pathway to produce siRNA, which in turn silences the retrotransposons in the following developmental stages. This hypothesis is supported by our observations that Dcr-2 but not Dcr-1, the two Drosophila dicer homologs, is predominantly expressed in the EGs, because Dcr-2 is responsible for the production of small interfering RNA (siRNA) from dsRNA, whereas Dcr-1 is for microRNA-triggered gene silencing (36–38). A recent analysis of the small RNAs expressed during Drosophila embryogenesis has identified a large number of repeat-associated siRNAs, which are complementary to repetitive elements, including retrotransposons (39). Although the distribution of these small RNAs remains unclear, it is likely that Dcr-2 and the other RNAi-related genes process transcripts from the LTR retrotransposons in the gonadal soma. Further studies examining the role of these RNAi-related genes in the EGs are required to investigate this hypothesis. SUMOylation. We found that almost all of the components required for SUMOylation are expressed predominantly in pole cells. SUMO is a member of the ubiquitin-like protein family that regulates cellular function by binding covalently to a variety of target proteins (40). SUMO (smt3) is one of the most highly represented transcripts in the EG EST collection (80 ESTs; Table 3). Our WISH analysis revealed that smt3 RNA is enriched in pole cells as well as in the CNS (Fig. 3 A large fraction of the SUMO substrates identified by global proteomics and studies in silico contribute to transcription (41, 42). Thus, SUMOylation may regulate germ-line gene expression by posttranslational modification of transcription factors. Indeed, our computational analysis reveals that the EG-EST collection contains a number of potential substrates for SUMOylation, including proteins involved in transcription (data not shown). To understand the role of SUMOylation in germ-line development, we are attempting to identify SUMO substrates with genetic and biochemical approaches. Germ-Line-Specific Ribosomal Proteins. Four genes (RpL22-like, RpS19b, RpS5b, and RpS13) encoding cytosolic ribosomal proteins are preferentially in pole cells within the EGs (Fig. 3 In addition to the ribosomal proteins, transcripts encoding translational regulators also are expressed preferentially in pole cells. For example, CG10990, which encodes a translational repressor distantly related to eIF4G and PDCD4 (43), was detected in pole cells in late embryos (Fig. 3 Alternatively, it is possible that the germ-line-specific ribosomal proteins carry out extraribosomal functions. It is plausible that the duplicated genes for ribosomal proteins acquire novel functions unrelated to their paralogs. This view is supported by our data that the germ-line-specific paralogs of the RpL22 and RpS19 families are more divergent than the universal ones; for example, the D. melanogaster RpL22 protein sequence is 57% identical to human RPL22, whereas germ-line-specific RpL22-like displays only 44% identity (14). Novel functions of ribosomal proteins have been reported. In human cells infected with Epstein–Barr virus, an appreciable portion of the RpL22 is not associated with ribosomes but is located in the nucleoplasm, where RpL22 binds to a small viral RNA (46). In addition, RpL22 has been identified as a protein associated with telomerase RNA (47). Thus, we speculate that the Drosophila paralogs of ribosomal proteins have acquired novel functions that contribute to germ-line development. The mechanism for germ-line-specific expression of the paralogs of ribosomal proteins is not yet clear. The similarity of their spatiotemporal expression is consistent with these genes being regulated in a coordinated fashion by germ-line-specific transcriptional machinery. An interesting case has been reported in Ascaris lumbricoides (48). Its genome encodes both germ-line- and soma-specific ribosomal proteins homologous to RpS19. A paralog, RpS19G, is expressed predominantly in the germ line but is eliminated from the genome of all somatic cells by chromatin diminution during early development. Instead, the other paralog, RpS19S, is expressed in the soma. Thus, we speculate that the differential expression of the ribosomal protein paralogs (and probably their function) is intimately related to the regulatory mechanism underlying germ-line development. Perspectives. Here we describe the gene expression data obtained from our EST analysis of purified EGs. Our transcriptome data provide unique genetic information to help in the understanding of gonad development. Furthermore, the spatiotemporal expression data of the gonad-enriched genes are useful for studying the regulatory mechanism of germ-line- and gonadal soma-specific gene expression and function. The general transcription factor TfIIA-S and transcription coactivator Ssb-c31a (Fig. 3 Materials and Methods Fly Stocks. EGs were collected from EGFP-vasa embryos (15) by FACS. y w flies were used for WISH analysis. Detailed procedures for WISH are described in Supporting Text. Construction of a cDNA Library from the FACS-Sorted EGs. The EG was isolated from EGFP-vasa transgenic embryos at 10–18 h after egg laying, as described (14). Microscopically, >99% of the total particles obtained by FACS were gonads (the number of particles we counted was >400). The remaining particles (<1%) were small noncellular clumps. A cDNA library was generated from ≈7 μg of total RNA, which was purified from 25,000 gonads by using the SMART system (Clontech, Mountain View, CA), as described (14). Two plasmids were used for cDNA construction, the pDNR-LIB vector (Clontech) and the pGEM-T Easy vector (Promega, Madison, WI). Information about primers used for EST sequencing is available in Table 6, which is published as supporting information on the PNAS web site. The clone name and corresponding EST accession no. used for each synthesis of the RNA probe are listed in Table 7, which is published as supporting information on the PNAS web site. EST Sequencing and Informatics. Each EST was sequenced, processed, and annotated as described (14). Detailed information is provided in Supporting Text. The bioinformatics analyses on (i) the analysis of repetitive ESTs, (ii) functional annotation based on GO and the statistical analysis, and (iii) the EST comparison among public EST collections and our EG library are also available in Supporting Text. Supporting Information
Acknowledgments We thank Dr. T. Akiyama (Azabu University, Fuchinobe, Japan) and Beckman Coulter (Fullerton, CA) for cell sorting, Dr. A. Nakamura (RIKEN, Kobe, Japan) for an anti-VASA antibody, and Mr. K. Hashiyama for WISH experiments. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology and the National Institute of Agrobiological Sciences and by the Core Research for Evolutional Science and Technology project of the Japan Science and Technology Agency. Abbreviations Footnotes References 1. Santos AC, Lehmann R. Curr Biol. 2004;14:R578–R589. [PubMed] 2. Williamson A, Lehmann R. Annu Rev Cell Dev Biol. 1996;12:365–391. [PubMed] 3. Hay B, Jan LY, Jan YN. Cell. 1988;55:577–587. [PubMed] 4. Asaoka-Taguchi M, Yamada M, Nakamura A, Hanyu K, Kobayashi S. Nat Cell Biol. 1999;1:431–437. [PubMed] 5. Sonnenblick BP. In: Biology of Drosophila. Demerec M, editor. Cold Spring Harbor, NY: Cold Spring Harbor Lab Press; 1994. pp. 62–167. 6. Asaoka M, Lin H. Development (Cambridge, UK). 2004;131:5079–5089. 7. DeFalco TJ, Verney G, Jenkins AB, McCaffery JM, Russell S, Van Doren M. Dev Cell. 2003;5:205–216. [PubMed] 8. Mukai M, Kashikawa M, Kobayashi S. Development (Cambridge, UK). 1999;126:1023–1029. 9. Jenkins AB, McCaffery JM, Van Doren M. Development (Cambridge, UK). 2003;130:4417–4426. 10. Wawersik M, Milutinovich A, Casper AL, Matunis E, Williams B, Van Doren M. Nature. 2005;436:563–567. [PubMed] 11. Le Bras S, Van Doren M. Dev Biol. 2006;294:92–103. [PubMed] 12. Andrews J, Bouffard GG, Cheadle C, Lu JN, Becker KG, Oliver B. Genome Res. 2000;10:2030–2043. [PubMed] 13. Parisi M, Nuttall R, Edwards P, Minor J, Naiman D, Lu J, Doctolero M, Vainer M, Chan C, Malley J, et al. Genome Biol. 2004;5:R40. [PubMed] 14. Shigenobu S, Arita K, Kitadate Y, Noda C, Kobayashi S. Dev Growth Differ. 2006;48:49–57. [PubMed] 15. Sano H, Nakamura A, Kobayashi S. Mech Dev. 2002;112:129–139. [PubMed] 16. Van Doren M, Williamson AL, Lehmann R. Curr Biol. 1998;8:243–246. [PubMed] 17. Cox DN, Chao A, Baker J, Chang L, Qiao D, Lin H. Genes Dev. 1998;12:3715–3727. [PubMed] 18. Tazuke SI, Schulz C, Gilboa L, Fogarty M, Mahowald AP, Guichet A, Ephrussi A, Wood CG, Lehmann R, Fuller MT. Development (Cambridge, UK). 2002;129:2529–2539. 19. Tomari Y, Du T, Haley B, Schwarz DS, Bennett R, Cook HA, Koppetsch BS, Theurkauf WE, Zamore PD. Cell. 2004;116:831–841. [PubMed] 20. Cook HA, Koppetsch BS, Wu J, Theurkauf WE. Cell. 2004;116:817–829. [PubMed] 21. Mukai M, Kitadate Y, Arita K, Shigenobu S, Kobayashi S. Gene Expr Patterns. 2006;6:256–266. [PubMed] 22. Ashburner M, Golic K, Howley R. Drosophila, a Laboratory Handbook. Cold Spring Harbor, NY: Cold Spring Harbor Lab Press; 2005. 23. Brookman JJ, Toosy AT, Shashidhara LS, White RA. Development (Cambridge, UK). 1992;116:1185–1192. 24. Ding D, Lipshitz HD. Genet Res. 1994;64:167–181. [PubMed] 25. Leblanc P, Desset S, Giorgi F, Taddei AR, Fausto AM, Mazzini M, Dastugue B, Vaury C. J Virol. 2000;74:10658–10669. [PubMed] 26. Song SU, Kurkulos M, Boeke JD, Corces VG. Development (Cambridge, UK). 1997;124:2789–2798. 27. Waksmonski SL, Woodruff RI. J Insect Physiol. 2002;48:667–675. [PubMed] 28. Aravin AA, Klenov MS, Vagin VV, Bantignies F, Cavalli G, Gvozdev V A. Mol Cell Biol. 2004;24:6742–6750. [PubMed] 29. Sijen T, Plasterk RH A. Nature. 2003;426:310–314. [PubMed] 30. Buchon N, Vaury C. Heredity. 2006;96:195–202. [PubMed] 31. Waterhouse PM, Wang M-B, Lough T. Nature. 2001;411:834–842. [PubMed] 32. Kavi HH, Fernandez HR, Xie W, Birchler JA. FEBS Lett. 2005;579:5940–5949. [PubMed] 33. Ronsseray S, Josse T, Boivin A, Anxolabehere D. Genetica. 2003;117:327–335. [PubMed] 34. Aravin AA, Naumova NM, Tulin AV, Vagin VV, Rozovsky YM, Gvozdev VA. Curr Biol. 2001;11:1017–1027. [PubMed] 35. Sarot E, Payen-Groschêne G, Bucheton A, Pelisson A. Genetics. 2004;166:1313–1321. [PubMed] 36. Okamura K, Ishizuka A, Siomi H, Siomi MC. Genes Dev. 2004;18:1655–1666. [PubMed] 37. Liu Q, Rand TA, Kalidas S, Du F, Kim H-E, Smith DP, Wang X. Science. 2003;301:1921–1925. [PubMed] 38. Lee YS, Nakahara K, Pham JW, Kim K, He Z, Sontheimer EJ, Carthew RW. Cell. 2004;117:69–81. [PubMed] 39. Aravin AA, Lagos-Quintana M, Yalcin A, Zavolan M, Marks D, Snyder B, Gaasterland T, Meyer J, Tuschl T. Dev Cell. 2003;5:337–350. [PubMed] 40. Johnson ES. Annu Rev Biochem. 2004;73:355–382. [PubMed] 41. Zhou F, Xue Y, Lu H, Chen G, Yao X. FEBS Lett. 2005;579:3369–3375. [PubMed] 42. Wohlschlegel JA, Johnson ES, Reed SI, Yates JR., III J Biol Chem. 2004;279:45662–45668. [PubMed] 43. Yang H-S, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH. Mol Cell Biol. 2003;23:26–37. [PubMed] 44. Kang M-J, Ahn H-S, Lee J-Y, Matsuhashi S, Park W-Y. Biochem Biophys Res Commun. 2002;293:617–621. [PubMed] 45. Kai T, Williams D, Spradling AC. Dev Biol. 2005;283:486–502. [PubMed] 46. Toczyski DP, Matera AG, Ward DC, Steitz JA. Proc Natl Acad Sci USA. 1994;91:3463–3467. [PubMed] 47. Le S, Greider CW, Sternglanz R. Mol Biol Cell. 2000;11:999–1010. [PubMed] 48. Etter A, Bernard V, Kenzelmann M, Tobler H, Müler F. Science. 1994;265:954–956. [PubMed] 49. Mathews WR, Ong D, Milutinovich AB, Van Doren M. Development (Cambridge, UK). 2006;133:1143–1153. 50. Potter SS, Brorein WJ, Jr, Dunsmuir P, Rubin GM. Cell. 1979;17:415–427. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Curr Biol. 2004 Jul 27; 14(14):R578-89.
[Curr Biol. 2004]Annu Rev Cell Dev Biol. 1996; 12():365-91.
[Annu Rev Cell Dev Biol. 1996]Cell. 1988 Nov 18; 55(4):577-87.
[Cell. 1988]Nat Cell Biol. 1999 Nov; 1(7):431-7.
[Nat Cell Biol. 1999]Dev Cell. 2003 Aug; 5(2):205-16.
[Dev Cell. 2003]Nature. 2005 Jul 28; 436(7050):563-7.
[Nature. 2005]Dev Biol. 2006 Jun 1; 294(1):92-103.
[Dev Biol. 2006]Genome Res. 2000 Dec; 10(12):2030-43.
[Genome Res. 2000]Mech Dev. 2002 Mar; 112(1-2):129-39.
[Mech Dev. 2002]Dev Growth Differ. 2006 Jan; 48(1):49-57.
[Dev Growth Differ. 2006]Curr Biol. 1998 Feb 12; 8(4):243-6.
[Curr Biol. 1998]Genes Dev. 1998 Dec 1; 12(23):3715-27.
[Genes Dev. 1998]Cell. 2004 Mar 19; 116(6):831-41.
[Cell. 2004]Cell. 2004 Mar 19; 116(6):817-29.
[Cell. 2004]Gene Expr Patterns. 2006 Mar; 6(3):256-66.
[Gene Expr Patterns. 2006]Genet Res. 1994 Dec; 64(3):167-81.
[Genet Res. 1994]J Virol. 2000 Nov; 74(22):10658-69.
[J Virol. 2000]J Insect Physiol. 2002 Jun; 48(6):667-675.
[J Insect Physiol. 2002]Mol Cell Biol. 2004 Aug; 24(15):6742-50.
[Mol Cell Biol. 2004]Nature. 2003 Nov 20; 426(6964):310-4.
[Nature. 2003]Genes Dev. 1998 Dec 1; 12(23):3715-27.
[Genes Dev. 1998]Cell. 2004 Mar 19; 116(6):817-29.
[Cell. 2004]Cell. 2004 Mar 19; 116(6):831-41.
[Cell. 2004]Heredity. 2006 Feb; 96(2):195-202.
[Heredity. 2006]Nature. 2001 Jun 14; 411(6839):834-42.
[Nature. 2001]FEBS Lett. 2005 Oct 31; 579(26):5940-9.
[FEBS Lett. 2005]Genetica. 2003 Mar; 117(2-3):327-35.
[Genetica. 2003]Curr Biol. 2001 Jul 10; 11(13):1017-27.
[Curr Biol. 2001]Genes Dev. 2004 Jul 15; 18(14):1655-66.
[Genes Dev. 2004]Science. 2003 Sep 26; 301(5641):1921-5.
[Science. 2003]Cell. 2004 Apr 2; 117(1):69-81.
[Cell. 2004]Dev Cell. 2003 Aug; 5(2):337-50.
[Dev Cell. 2003]Annu Rev Biochem. 2004; 73():355-82.
[Annu Rev Biochem. 2004]FEBS Lett. 2005 Jun 20; 579(16):3369-75.
[FEBS Lett. 2005]J Biol Chem. 2004 Oct 29; 279(44):45662-8.
[J Biol Chem. 2004]Dev Growth Differ. 2006 Jan; 48(1):49-57.
[Dev Growth Differ. 2006]Mol Cell Biol. 2003 Jan; 23(1):26-37.
[Mol Cell Biol. 2003]Biochem Biophys Res Commun. 2002 Apr 26; 293(1):617-21.
[Biochem Biophys Res Commun. 2002]Dev Biol. 2005 Jul 15; 283(2):486-502.
[Dev Biol. 2005]Dev Growth Differ. 2006 Jan; 48(1):49-57.
[Dev Growth Differ. 2006]Proc Natl Acad Sci U S A. 1994 Apr 12; 91(8):3463-7.
[Proc Natl Acad Sci U S A. 1994]Mol Biol Cell. 2000 Mar; 11(3):999-1010.
[Mol Biol Cell. 2000]Science. 1994 Aug 12; 265(5174):954-6.
[Science. 1994]Dev Biol. 2006 Jun 1; 294(1):92-103.
[Dev Biol. 2006]Mech Dev. 2002 Mar; 112(1-2):129-39.
[Mech Dev. 2002]Dev Growth Differ. 2006 Jan; 48(1):49-57.
[Dev Growth Differ. 2006]Dev Growth Differ. 2006 Jan; 48(1):49-57.
[Dev Growth Differ. 2006]Cell. 1979 Jun; 17(2):415-27.
[Cell. 1979]